MSB 3.21% $1.13 mesoblast limited

FDA ODAC Meeting Material discussion analysis, page-284

  1. 15,643 Posts.
    lightbulb Created with Sketch. 5711
    USA time @rick64

    Thanks @The Yankee for your detailed analysis again this morning

    @thrasher it is not about being right or wrong regarding Remestemcel-L .... it's more about your ignorance on MSB with your "one trick pony" comment ... lol .... Three phase 3 readouts due in the next 6 weeks for three very different illnesses / treatments for starters - enough said

    A quick read of the threads shows that it could be another day to only read the ones with high numbers of TU's IMO .... There are some brilliant posts of great information clearly demonstrated by the 20+ and 50+ TU's ... you be the judge

    I hope the company trips everyone up this morning and puts us into a TH before open - just sayin'

    Have a great day MSB'ers
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.